Insmed Presents Broad Range of Data Across Its Three Programs at the American Thoracic Society 2021 International Conference
Insmed Presents Broad Range of Data Across Its Three Programs at the American Thoracic Society 2021 International Conference -Retrospective analysis of patients with COPD and NTM lung disease demonstrates statistically significantly higher mortality compared to patients with COPD without NTM lung disease- -Post-hoc analysis from ARIKAYCE® (amikacin liposome inhalation suspension) clinical trials supports favorable benefit and safety profile, with a low number needed to treat (NNT) and high number needed to harm (NNH)- News provided by Share this article Share this article BRIDGEWATER, N.J., ...
Source: prnewswire.com